HSPD1 and ovarian cancer: HSP60 was shown to be overexpressed in several tumor types, which include non-small cell lung cancer (NSCLC) [10], colorectal cancer [11], breast cancer [12] as well as ovarian cancer [13] and HSP60 overexpression has also been linked with poor prognosis.